Epsilon Healthcare Ltd Stock Fundamentals
| 9TH0 Stock | EUR 0.01 0.00 0.00% |
EPSILON HEALTHCARE LTD fundamentals help investors to digest information that contributes to EPSILON HEALTHCARE's financial success or failures. It also enables traders to predict the movement of EPSILON Stock. The fundamental analysis module provides a way to measure EPSILON HEALTHCARE's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to EPSILON HEALTHCARE stock.
EPSILON |
EPSILON HEALTHCARE LTD Company Shares Outstanding Analysis
EPSILON HEALTHCARE's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current EPSILON HEALTHCARE Shares Outstanding | 300.35 M |
Most of EPSILON HEALTHCARE's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, EPSILON HEALTHCARE LTD is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, EPSILON HEALTHCARE LTD has 300.35 M of shares currently outstending. This is 66.37% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all Germany stocks is 47.47% higher than that of the company.
EPSILON HEALTHCARE LTD Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining EPSILON HEALTHCARE's current stock value. Our valuation model uses many indicators to compare EPSILON HEALTHCARE value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across EPSILON HEALTHCARE competition to find correlations between indicators driving EPSILON HEALTHCARE's intrinsic value. More Info.EPSILON HEALTHCARE LTD is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the EPSILON HEALTHCARE's earnings, one of the primary drivers of an investment's value.EPSILON Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses EPSILON HEALTHCARE's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of EPSILON HEALTHCARE could also be used in its relative valuation, which is a method of valuing EPSILON HEALTHCARE by comparing valuation metrics of similar companies.EPSILON HEALTHCARE is currently under evaluation in shares outstanding category among its peers.
EPSILON Fundamentals
| Return On Equity | -0.81 | |||
| Return On Asset | -0.14 | |||
| Profit Margin | (2.41) % | |||
| Operating Margin | (1.12) % | |||
| Shares Outstanding | 300.35 M | |||
| Shares Owned By Insiders | 28.06 % | |||
| Shares Owned By Institutions | 0.03 % | |||
| Revenue | 5.46 M | |||
| Gross Profit | 1.92 M | |||
| EBITDA | (5.27 M) | |||
| Net Income | (10.54 M) | |||
| Cash And Equivalents | 6.97 M | |||
| Cash Per Share | 0.04 X | |||
| Total Debt | 5.11 M | |||
| Debt To Equity | 0.20 % | |||
| Current Ratio | 1.55 X | |||
| Book Value Per Share | 0.04 X | |||
| Cash Flow From Operations | (8.69 M) | |||
| Earnings Per Share | (0.03) X | |||
| Beta | 1.27 | |||
| Market Capitalization | 4.83 M |
About EPSILON HEALTHCARE Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze EPSILON HEALTHCARE LTD's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of EPSILON HEALTHCARE using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of EPSILON HEALTHCARE LTD based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Epsilon Healthcare Limited operates as a healthcare and pharmaceuticals company primarily in Australia and Canada. Epsilon Healthcare Limited was incorporated in 2016 and is based in Sydney, Australia. EPSILON HEALTHCARE operates under Drug ManufacturersSpecialty Generic classification in Germany and is traded on Frankfurt Stock Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in EPSILON Stock
EPSILON HEALTHCARE financial ratios help investors to determine whether EPSILON Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in EPSILON with respect to the benefits of owning EPSILON HEALTHCARE security.